GH SEC Filing News — Guardant Health, Inc.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Saia John G. (Chief Legal Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Monroe Terilyn J. (Chief People Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Kalia Kumud (Chief Information Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Freeman Chris (Chief Commercial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Chudova Darya (Chief Technology Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Bell Michael Brian (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Talasaz AmirAli (Director, Co-Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Eltoukhy Helmy (Director, Co-Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

MIGNONE ROBERTO (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Hidalgo Medina Manuel (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Chudova Darya (Chief Technology Officer) sold 7,738 shares (~$1.38M)

Chudova Darya, listed as Chief Technology Officer at Guardant Health, Inc., reported an open-market sale of 7,738 GH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

GH insider Krognes Steve E. (Director) sold 6,674 shares (~$1.17M)

Krognes Steve E., listed as Director at Guardant Health, Inc., reported an open-market sale of 6,674 GH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

GH insider Azar Alex M II (Director) sold 826 shares (~$144.6K)

Azar Alex M II, listed as Director at Guardant Health, Inc., reported an open-market sale of 826 GH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

GH insider Tariq Musa (Director) sold 116 shares (~$20.3K)

Tariq Musa, listed as Director at Guardant Health, Inc., reported an open-market sale of 116 GH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

GH insider Form 4 filed for equity award, exercise, or tax withholding

Azar Alex M II (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

GH insider Kalia Kumud (Chief Information Officer) sold 4,000 shares (~$632.2K)

Kalia Kumud, listed as Chief Information Officer at Guardant Health, Inc., reported an open-market sale of 4,000 GH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

GH Form 144 filed for proposed insider sale by Tariq Musa (116 shares) ~$20.3K

Tariq Musa filed a Form 144 with the SEC indicating intent to sell GH (Guardant Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

GH Form 144 filed for proposed insider sale by Azar Alex M II (826 shares) ~$144.6K

Azar Alex M II filed a Form 144 with the SEC indicating intent to sell GH (Guardant Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

GH Form 144 filed for proposed insider sale by Krognes Steve E. (6,674 shares) ~$1.17M

Krognes Steve E. filed a Form 144 with the SEC indicating intent to sell GH (Guardant Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

GH Form 144 filed for proposed insider sale by Chudova Darya (7,738 shares) ~$1.38M

Chudova Darya filed a Form 144 with the SEC indicating intent to sell GH (Guardant Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.